Martin Stockler (@martinstockler) 's Twitter Profile
Martin Stockler

@martinstockler

Grappling with oncology, clinical research, quality of life, prognostication, communication, education, rabbitohs, wallabies, cricket, and other enigmas

ID: 177787568

linkhttp://sydney.edu.au/medicine/people/academics/profiles/martin.stockler.php calendar_today13-08-2010 02:02:47

17,17K Tweet

2,2K Followers

3,3K Following

Martin Stockler (@martinstockler) 's Twitter Profile Photo

Eagerly awaiting Dark Noon @ #SydneyTownHall with JPS , event 6 of our 2025 #SydFest #SydneyFestival @Sydney_Festival sydneyfestival.org.au/events/dark-no…

The Lancet Oncology (@thelancetoncol) 's Twitter Profile Photo

Being presented at ASCO #GU25 ⬇️ Overall survival & QOL results from ENZA-p: [177Lu]Lu-PSMA-617 plus enzalutamide vs enzalutamide in metastatic castration-resistant #prostatecancer Louise Emmett Ian Davis Michael Hofman Martin Stockler ANZUP bit.ly/3ExZgPI

Common Sense Oncology (@csoncol) 's Twitter Profile Photo

CSO Webinar announcement! 📣 Register today! Join Dr. Anuradha Vasista and Dr. Deme Karikios as we talk about discussing prognosis with patients living with advanced cancers. The webinar will take place on Zoom on March 19th at 7:00 pm Australian Eastern Daylight Time (8:00 am

CSO Webinar announcement! 📣 Register today! 

Join Dr. Anuradha Vasista and Dr. Deme Karikios as we talk about discussing prognosis with patients living with advanced cancers.

The webinar will take place on Zoom on March 19th at 7:00 pm Australian Eastern Daylight Time (8:00 am
Common Sense Oncology (@csoncol) 's Twitter Profile Photo

Common Sense Oncology is hosting our next Annual Meeting on April 8th in Montreal! Join us LIVE for the Open Plenary Session with keynote speakers Monica Bertagnolli, CS Pramesh, Henry Scowcroft, and Elizabeth Eisenhauer! Link to register: us06web.zoom.us/webinar/regist…

Common Sense Oncology is hosting our next Annual Meeting on April 8th in Montreal!

Join us LIVE for the Open Plenary Session with keynote speakers Monica Bertagnolli, CS Pramesh, Henry Scowcroft, and Elizabeth Eisenhauer!

Link to register: us06web.zoom.us/webinar/regist…
Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo

Very excited to be joining the ANZUP Annual Meeting for the first time, after having admired the group for several years for doing patient centric trials in GU cancers. Even more excited to meet new and old friends and colleagues. Carole Harris Dr Deme Karikios Ian Davis (Bluesky @profiand)

Dave (@mesut_ausil) 's Twitter Profile Photo

Flew to Darwin on a whim to watch the Raiders big. Met Colin from the Tiwi Islands. He has sons named Gary, Steve and Bradley after Belcher, Walters and Clyde. He has a daughter named Ricky. I love rugby league

Flew to Darwin on a whim to watch the Raiders big. Met Colin from the Tiwi Islands. He has sons named Gary, Steve and Bradley after Belcher, Walters and Clyde. He has a daughter named Ricky. I love rugby league
Nicolas Hart (@drnicolashart) 's Twitter Profile Photo

Coming to ASCO in-person or virtual (on-demand)? Make sure you attend our Session on 1st June, Sunday (GMT-5) at 8am - Larissa Nekhlyudov FASCO, Prof Michael Jefford FASCO, Dr Andrea Smith, and I expand on the MASCC-ASCO Survivorship Care Standards for Advanced or Metastatic Cancer.

Coming to <a href="/ASCO/">ASCO</a> in-person or virtual (on-demand)? Make sure you attend our Session on 1st June, Sunday (GMT-5) at 8am - <a href="/DrN_CancerPCP/">Larissa Nekhlyudov</a> FASCO, Prof Michael Jefford FASCO, <a href="/DrAndreaLSmith/">Dr Andrea Smith</a>, and I expand on the MASCC-ASCO Survivorship Care Standards for Advanced or Metastatic Cancer.
Edmond Kwan (@edmondmkwan) 's Twitter Profile Photo

On the eve of #ASCO25, I am delighted to share results from the correlative analyses of the ANZUP phase II TheraP study, now published in Nature Medicine. Massive effort supported by dedicated co-investigators, coordinators, patients & families from 11 study sites across

On the eve of #ASCO25, I am delighted to share results from the correlative analyses of the <a href="/ANZUPtrials/">ANZUP</a> phase II TheraP study, now published in <a href="/NatureMedicine/">Nature Medicine</a>. Massive effort supported by dedicated co-investigators, coordinators, patients &amp; families from 11 study sites across
Michael Serzan, MD (@mikeserzanmd) 's Twitter Profile Photo

🗣️Bladder Cancer Oral Abstracts #ASCO25 👉LBA4504: Dr #DickonHayne presenting intravesicular Mitomycin plus BCG for high-risk NMIBC #ANZUP1301 N = 501 (HG papillary UC (pTa/pT1; CIS) median F/u 47mo 💉 BCG+Mitomycin 💉 BCG-alone 📊 DFS at 2 yr: 76% vs 71% (0.86

🗣️Bladder Cancer Oral Abstracts #ASCO25

👉LBA4504: Dr #DickonHayne presenting intravesicular Mitomycin plus BCG for high-risk NMIBC  #ANZUP1301

N = 501 (HG papillary UC (pTa/pT1;  CIS)
median F/u 47mo 

💉 BCG+Mitomycin
💉 BCG-alone

📊 DFS at 2 yr:  76% vs 71%  (0.86
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Viewpoint: Despite advances in data reconstruction and sharing initiatives, limited access to individual patient data from cancer trials hinders research progress. ja.ma/4ldA01G Ludovic Trinquart @martinstockler

Viewpoint: Despite advances in data reconstruction and sharing initiatives, limited access to individual patient data from cancer trials hinders research progress. 

ja.ma/4ldA01G <a href="/l_trinquart/">Ludovic Trinquart</a> @martinstockler